Lowell Schiller, JD - USC Schaeffer
Lowell Schiller is a Nonresident Senior Scholar at the USC Schaeffer Institute. He has held senior leadership roles in health law and policy in both the| USC Schaeffer
The Schaeffer Center produces annual reports which highlight priority areas and faculty research.| USC Schaeffer
Lowell Schiller is a Nonresident Senior Scholar at the USC Schaeffer Institute. He has held senior leadership roles in health law and policy in both the| USC Schaeffer
A new Schaeffer Center white paper demonstrates why meaningful 340B reform must end “spread pricing,” in which participating providers buy discounted drugs and bill insurers at higher rates. The post Reform of Federal Drug Discount Program Should Target Misaligned Incentives appeared first on USC Schaeffer.| USC Schaeffer
340B providers leverage spread pricing to generate revenue, creating unintended consequences in the broader healthcare market. This white paper addresses potential opportunities to restructure program benefits. The post Cui Bono? Misaligned Incentives in the 340B Program appeared first on USC Schaeffer.| USC Schaeffer
The post Padula discusses Trump’s drug pricing reduction claims appeared first on USC Schaeffer.| USC Schaeffer
Understanding how water insecurity shapes people’s perceptions of the world and its risks can inform more effective communication strategies and strengthen community trust and resilience. The post What Water Insecurity Teaches Us About Disaster Preparedness appeared first on USC Schaeffer.| USC Schaeffer
Advances in rare disease treatments and clinical trial tools demand new regulatory frameworks, former commissioners said a Schaeffer Center conference on FDA reform. The post Former FDA Leaders Say New Policies Needed to Boost Medical Innovation appeared first on USC Schaeffer.| USC Schaeffer
Overuse of antibiotics can lead to drug-resistant bacteria, “a problem for the whole world, not just India,” study finds. The post Provider Misperceptions, Not Knowledge or Profit, Drive Inappropriate Antibiotic Prescribing in India appeared first on USC Schaeffer.| USC Schaeffer
The post Pacula quoted on new California legislation to counter the illicit cannabis market appeared first on USC Schaeffer.| USC Schaeffer
For more than a decade, the Leonard D. Schaeffer Fellows in Government Service program has supported students in high-level government internships to foster career development — and democracy. The post Government Internships Put Students on the Front Lines of Public Service appeared first on USC Schaeffer.| USC Schaeffer
Sarah Axeen, PhD is Director of Data and Analytics at the USC Schaeffer Center and an assistant professor of research in the Department of Emergency| USC Schaeffer
Dima Mazen Qato, PharmD, MPH, PhD serves as the Hygeia Centennial Chair and Associate Professor (with tenure) in the Titus Family Department of Clinical| USC Schaeffer
About the Program Alumna Pursues Career in Nuclear Policy Research Jamie Kwong’s 2016 Schaeffer Fellowship with the House Foreign Affairs Subcommittee on Asia and the Pacific was a pivotal moment in launching her career in nuclear weapons diplomacy. While a senior, Jamie was selected for the prestigious Marshall Scholarship. After earning both a bachelor’s and...| USC Schaeffer
Schaeffer Center for Health Policy & Economics | USC Schaeffer
Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint, (now Elevance), which now serves 47.0 million medical members and has annualized| USC Schaeffer
Dana P. Goldman is a University Professor of Public Policy, Pharmacy, and Economics at the University of Southern California and the Leonard D. Schaeffer| USC Schaeffer
The USC Schaeffer Institute helps shape creative policy solutions to pressing national and global challenges through rigorous, independent research and close engagement with public and private-sector leaders.| USC Schaeffer
The post Kanter discusses modernizing industry payment transparency to keep pace with medical AI adoption appeared first on USC Schaeffer.| USC Schaeffer
The new center headed by former UK Prime Minister Gordon Brown aims to bolster democracy and strengthen civic trust at home and abroad. - September 15, 2025| USC Schaeffer
To harness the full potential of new medical technologies, a new white paper calls for significant FDA reforms to streamline clinical trials, provide greater certainty for innovators and speed game-changing treatments to more patients. - September 11, 2025| USC Schaeffer
We propose a set of recommended actions FDA should take to accelerate development of transformative medical technologies and enhance patient access. - September 11, 2025| USC Schaeffer
Rosalie Liccardo Pacula holds the Elizabeth Garrett Chair in Health Policy, Economics & Law in the Health Policy and Management Department at the USC| USC Schaeffer
Establishing value-based drug prices using GRACE costs about the same as using traditional cost-effectiveness analysis. - September 5, 2025| USC Schaeffer
Shifts in racial patterns of opioid overdose deaths are closely tied to how changes in the drug supply interact with where poeple live, new research shows. - September 2, 2025| USC Schaeffer
Even as policymakers have made it much easier to prescribe buprenorphine, a new Schaeffer Center study finds most pharmacies still aren't carrying the treatment. - September 2, 2025| USC Schaeffer
Homepage | USC Schaeffer
Although the Inflation Reduction Act's out-of-pocket Part D cap adds important protection for beneficiaries, its implementation incentivized plans to increase beneficiary exposure to cost sharing prior to reaching that limit. - June 19, 2025| USC Schaeffer
